Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers

NCT02084251 is registered in ClinicalTrials.gov with PegBio Co., Ltd. as lead sponsor.

NCT NCT02084251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02084251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Tolerability and Pharmacokinetics of Single Dose of PB-119 in Healthy Volunteers
Lead sponsor
PegBio Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2014
Completion date
November 30, 2014
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type ii diabetes